Effects of B7.1, IFN-gamma, and antisense TGF-beta gene transfer on the tumorigenicity of murine 4T1 metastatic mammary carcinoma cells

Persistent Link:
http://hdl.handle.net/10150/280475
Title:
Effects of B7.1, IFN-gamma, and antisense TGF-beta gene transfer on the tumorigenicity of murine 4T1 metastatic mammary carcinoma cells
Author:
Wu, Rita Shiu-fung
Issue Date:
2001
Publisher:
The University of Arizona.
Rights:
Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
Abstract:
Cancer progression is attributed in part to immune evasion strategies that include lack of co-stimulation, down-regulation of cell surface MHC molecules, and secretion of immunosuppressive factors such as transforming growth factor-β (TGF-β). Gene therapy has been employed to counter these mechanisms of immune evasion by transference of B7.1, IFN-γ or antisense TGF-β genes into tumor cells resulting in cell surface expression of B7.1, upregulation of MHC class I and class II molecules, or elimination tumor-derived TGF-β, respectively. Although each of these transgenes has been shown to alter tumorigenicity in murine models, a direct comparison of their efficacy has not been performed. To compare the effectiveness of these transgenes in eliciting an anti-tumor response, a very aggressive, poorly immunogenic and highly metastatic mammary tumor cell line 4T1, was genetically modified to express B7.1, IFN-γ and antisense TGF-β transgenes. Both IFN-γ and antisense TGF-β gene expression significantly reduced the tumorigenicity of these cells compared to mock transduced cells, with IFN-γ having a greater effect. In contrast, B7.1 gene transfer did not affect the tumorigenicity of 4T1 cells. The anti-tumor response directed against antisense TGF-β-expressing 4T1 tumors was mediated by CD4+ and CD8+ T cells. However, CD8+ T cells and not CD4+ T cells, appeared to mediate the anti-tumor response against IFN-γ-expressing tumors. Treatment of tumor-bearing animals with IFN-γ or antisense TGF-β gene-modified tumor cell vaccines reduced the number of clonogenic metastases to the lungs and liver compared to treatment with mock-transduced cells. Finally, in a residual disease model in which the primary tumor was excised and mice were vaccinated with irradiated tumor cells, treatment of mice with vaccinations consisting of 4T1 cells expressing both antisense TGF-β and IFN-γ genes was the most effective in prolonging survival.
Type:
text; Dissertation-Reproduction (electronic)
Keywords:
Biology, Microbiology.; Health Sciences, Immunology.; Health Sciences, Oncology.
Degree Name:
Ph.D.
Degree Level:
doctoral
Degree Program:
Graduate College; Microbiology and Immunology
Degree Grantor:
University of Arizona
Advisor:
Akporiaye, Emmanuel T.

Full metadata record

DC FieldValue Language
dc.language.isoen_USen_US
dc.titleEffects of B7.1, IFN-gamma, and antisense TGF-beta gene transfer on the tumorigenicity of murine 4T1 metastatic mammary carcinoma cellsen_US
dc.creatorWu, Rita Shiu-fungen_US
dc.contributor.authorWu, Rita Shiu-fungen_US
dc.date.issued2001en_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.description.abstractCancer progression is attributed in part to immune evasion strategies that include lack of co-stimulation, down-regulation of cell surface MHC molecules, and secretion of immunosuppressive factors such as transforming growth factor-β (TGF-β). Gene therapy has been employed to counter these mechanisms of immune evasion by transference of B7.1, IFN-γ or antisense TGF-β genes into tumor cells resulting in cell surface expression of B7.1, upregulation of MHC class I and class II molecules, or elimination tumor-derived TGF-β, respectively. Although each of these transgenes has been shown to alter tumorigenicity in murine models, a direct comparison of their efficacy has not been performed. To compare the effectiveness of these transgenes in eliciting an anti-tumor response, a very aggressive, poorly immunogenic and highly metastatic mammary tumor cell line 4T1, was genetically modified to express B7.1, IFN-γ and antisense TGF-β transgenes. Both IFN-γ and antisense TGF-β gene expression significantly reduced the tumorigenicity of these cells compared to mock transduced cells, with IFN-γ having a greater effect. In contrast, B7.1 gene transfer did not affect the tumorigenicity of 4T1 cells. The anti-tumor response directed against antisense TGF-β-expressing 4T1 tumors was mediated by CD4+ and CD8+ T cells. However, CD8+ T cells and not CD4+ T cells, appeared to mediate the anti-tumor response against IFN-γ-expressing tumors. Treatment of tumor-bearing animals with IFN-γ or antisense TGF-β gene-modified tumor cell vaccines reduced the number of clonogenic metastases to the lungs and liver compared to treatment with mock-transduced cells. Finally, in a residual disease model in which the primary tumor was excised and mice were vaccinated with irradiated tumor cells, treatment of mice with vaccinations consisting of 4T1 cells expressing both antisense TGF-β and IFN-γ genes was the most effective in prolonging survival.en_US
dc.description.noteDigitization note: p. 81, 84-85 missing from paper original.-
dc.typetexten_US
dc.typeDissertation-Reproduction (electronic)en_US
dc.subjectBiology, Microbiology.en_US
dc.subjectHealth Sciences, Immunology.en_US
dc.subjectHealth Sciences, Oncology.en_US
thesis.degree.namePh.D.en_US
thesis.degree.leveldoctoralen_US
thesis.degree.disciplineGraduate Collegeen_US
thesis.degree.disciplineMicrobiology and Immunologyen_US
thesis.degree.grantorUniversity of Arizonaen_US
dc.contributor.advisorAkporiaye, Emmanuel T.en_US
dc.identifier.proquest3010256en_US
dc.identifier.bibrecord.b41711701en_US
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.